
Indian drug manufacturer Lupin has announced the completion of its acquisition of New Jersey-based pharmaceutical firm, Gavis, in a deal …

Indian drug manufacturer Lupin is expanding to the US by purchasing Gavis pharma for $880 million, in a major boost …
AstraZeneca’s Trixeo approved in EU for asthma
ESTEVE CDMO adds $17.5m to Illinois expansion

